Cordyceps

The VerdictLOW CONVICTION

Three different fungi marketed as one supplement, with claims that outrun the human evidence everywhere except specialist-care kidney medicine.

Next time you see "Cordyceps for endurance" on a label, skip it. The biggest blinded trial in trained cyclists found exactly zero improvement in 2004 — and 22 years of follow-up trials haven't overturned it.

The biggest blinded endurance trial in trained cyclists found zero improvement at three grams a day for five weeks — that was 22 years ago and nothing since has overturned it; 2) Most people get this wrong by thinking "C. sinensis" on the bottle means wild caterpillar fungus — it almost never does, and the premium price tier is buying heritage and rarity, not pharmacology; 3) If you're trialling anyway, set a 4-6 week stopping rule with one objective performance metric (5-km TT, repeatable interval RPE, HRV trend) — if it doesn't move the metric, stop.

Cordyceps isn't one thing. It's three different fungi sold under one label — like buying "orange juice" that turns out to be three different fruits blended depending on the bottle, then sold with the marketing of the rarest one. The "wild caterpillar fungus" on the premium bottle almost never contains the wild caterpillar fungus; it's mycelium grown in a fermenter. And the active ingredient your body is supposed to absorb gets destroyed in your plasma within minutes.

That's the general answer. Your stack is different.

Check your whole stack

Next time you see "Cordyceps for endurance" on a supplement label, skip it. You just saved £15-40 a month.

The biggest blinded trial of the standard dose in trained cyclists found zero improvement in VO₂max or time-to-exhaustion. That was 2004, and 22 years of follow-up trials haven't overturned it. Rhodiola and ashwagandha cover the same marketing space with better evidence.

Takes less than 30 seconds. Ask yourself: am I a CKD patient under a nephrologist? If no, this is a save-your-money decision.

The Verdict

Three different fungi sold as one supplement, with claims that outrun the evidence everywhere except specialist kidney care.

Cordyceps is a fungus, not a single molecule. It's actually three different fungi sold under one label — like buying "orange juice" that turns out to be three different fruits blended depending on the bottle, then sold with the marketing of the rarest one. The "wild caterpillar fungus" on the premium bottle almost never contains the wild caterpillar fungus; that material basically cannot be cultivated and most of what's sold is mycelium grown in a fermenter. The active ingredient supposed to drive performance gets destroyed in your plasma within minutes.

The biggest blinded endurance trial in trained cyclists gave them three grams of cordyceps a day for five weeks and found exactly zero improvement in VO₂max, time-to-exhaustion, or ventilatory threshold. That was 22 years ago. Nothing independent has overturned it since.
Most people get this wrong by assuming "Cordyceps sinensis" on the bottle means wild caterpillar fungus from Tibet. It almost never does. The premium "wild" tier at £500 a gram is buying heritage and rarity, not pharmacology, and authentic wild material is essentially unavailable to retail consumers.
If you're trialling it anyway, set a stopping rule: C. militaris fruiting body, three to four grams a day (about one small scoop), for four to six weeks, with one objective performance metric you check every week. If the metric doesn't move, stop. No loading phase — no evidence supports one.

Best for

CKD, kidney transplant, hemodialysis, or lung-cancer chemotherapy patients under nephrologist or oncologist supervision using specific Chinese pharmaceutical-grade preparations (Bailing, Jinshuibao, Corbrin).

Skip if

You're buying for energy, endurance, longevity, fat loss, testosterone, cortisol, or cognition. Also skip if you're on warfarin, pre-op, pregnant, breastfeeding, under 18, or have active autoimmune disease.

Want the full evidence? Keep scrolling

The Protocol

If you're going to take it, here's what the evidence actually supports — and where it doesn't.

Cordyceps protocol — atmospheric macro of mycelial culture textures

Dosing

Population	Dose	Duration	Form	Loading?
Retail healthy adult — wellness / energy / longevity	NOT INDICATED	—	—	No
Healthy adult — endurance trial-with-stopping-rule	3-4 g/d (about 1 small scoop)	4-6 wk; stop if no objective change	C. militaris fruiting body	No
Healthy adult — immune biomarker curiosity	1.5-3 g/d	4-8 wk	C. militaris fruiting body	No
CKD / DKD / hemodialysis adjunctive — specialist care only	2-5 g/d, specialist-directed	1-6 mo	Bailing / Jinshuibao / Corbrin	No
Kidney transplant adjunctive — specialist care only	2-5 g/d, transplant-physician-directed	Specialist-directed	Branded Chinese preparation	No
Lung cancer chemo-adjunctive — specialist care only	Trial-specific	With chemo regimen	Branded Chinese preparation	No

Forms Comparison

C. militaris fruiting body

£15-40/mo

Best for healthy-adult biomarker work — the only form that reliably contains cordycepin.

Form used in Park 2015 and Lee 2024 immune-biomarker RCTs.

Mycelial Cs-4 (Hirsutella sinensis)

£20-40/mo

The renal-trial form — Chinese pharmaceutical-grade brands (Bailing, Jinshuibao).

Specialist-care only; high-RoB underlying trials.

"High-cordycepin" extracts

£25-60/mo

Marketing tier — no head-to-head outcome RCT vs standard fruiting body.

Pay more for an unproven advantage.

Wild Ophiocordyceps sinensis

£300-1000+/g

Heritage and rarity, not pharmacology — virtually unavailable in authentic form.

No outcome RCT advantage; arsenic contamination documented.

Cordyceps + Rhodiola blends

£25-50/mo

Combo design destroys attribution — Colson 2005 combo trial failed primary.

Branded products like Optygen.

"Liposomal" cordyceps

£40-80/mo

Premium-form marketing — no human PK or outcome RCT.

Outcome superiority NONE.

Absorption tips: Take with food to reduce GI upset at higher doses. No documented cofactors or absorption enhancers studied in humans. Cordycepin's plasma clearance by adenosine deaminase is the dominant pharmacokinetic ceiling and cannot be solved by formulation choices currently on the market.

Safety & Interactions

Drug Interactions

Anticoagulants (warfarin, DOACs) — Moderate theoretical

Cordycepin has reported in vitro platelet aggregation inhibition. Avoid combining or monitor closely. Cease at least 2 weeks before any scheduled surgery.

Immunosuppressants (cyclosporine, tacrolimus) — Specialist-supervised only

Used adjunctively in kidney transplant trials under specialist supervision. Pharmacokinetic interaction not formally characterised. Do not self-add to an immunosuppression regimen.

Hypoglycaemic agents (metformin, insulin, sulfonylureas) — Low-moderate theoretical

Theoretical additive glucose lowering from animal and Chinese-medicine reports. Monitor blood glucose if combining.

Antiplatelet agents (aspirin, clopidogrel) — Low-moderate theoretical

Theoretical additive antiplatelet effect. Avoid or monitor.

Contraindicated populations

Pregnancy and lactation: No safety data. Default contraindicated.
Children: No safety data. Not validated.
Active autoimmune disease (lupus, RA, MS, IBD flare, psoriasis): Theoretical immune activation via polysaccharide-driven TLR2/4 signalling could exacerbate disease activity.
Active cancer / chemotherapy not under oncology supervision: Medicinal-mushroom adjunctive use is a clinician-directed decision.
Bleeding disorders or scheduled surgery within 2 weeks: Theoretical platelet aggregation effect.
Patients on immunosuppressants without specialist supervision.
"Wild O. sinensis" buyers without DNA authentication: High adulteration rate; documented arsenic accumulation.

Upper limit

No formally established Tolerable Upper Intake Level. Safety RCT ceiling 3 g/d × 12 weeks (Kang 2021, PMID 32702252). GI upset (loose stool) reported at ≥4 g/d. Long-term safety beyond ~6 months: data unavailable.

Conviction

LOW overall — endpoint-stratified

Specialist-care renal / oncology adjunctive: MODERATE. Cellular immunity biomarker in healthy adults: MODERATE biomarker-only. Retail endurance / energy / longevity / cortisol / fat loss / testosterone / cognition: LOW to DEBUNKED-by-absence. Cordycepin pharmacokinetics at oral consumer doses: CONTRADICTED. Premium-form outcome superiority: NONE.

What would change this

A double-blind, placebo-controlled, independently-funded RCT of N≥80 trained athletes (VO₂max ≥55 ml/kg/min) on C. militaris fruiting body 4 g/d × ≥8 weeks, with a per-protocol cordycepin pharmacokinetic substudy demonstrating measurable plasma cordycepin AUC, AND ≥3% absolute VO₂max improvement OR ≥2% time-trial improvement vs placebo — would upgrade endurance conviction to MODERATE. The Lindenwood NCT07310108 trial (Kerksick et al., 2025-registered) is the candidate. Until it reports something like this, endurance conviction stays LOW.

Worth Your Money?

Weekly cost£4-10 per week at retail forms (£15-40/month). Premium "wild" tier £125-500+/week — no outcome-RCT advantage.

Worth it ifYou're a CKD, kidney transplant, hemodialysis, or lung-cancer chemotherapy patient under specialist supervision using a specific Chinese pharmaceutical-grade preparation (not a retail capsule).

Lower priority ifYou're a healthy adult trying to "boost energy" or "improve endurance" — your next £30 is better spent on creatine, sodium bicarbonate, beetroot/nitrate, or caffeine for performance; on ashwagandha or rhodiola for cortisol and fatigue with better evidence; or on improving sleep, protein, and training basics first.

Skip (for retail use) Conditional Value (specialist care only)

Go Deeper

Want to stop wasting money on supplements that don't work? The Verdict reviews one every week — evidence-graded, no affiliate links, free.

Subscribe — it's free

Sources

Earnest CP, et al. (2004). Effects of a commercial herbal-based formula on exercise performance in cyclists. Med Sci Sports Exerc. PMID 15118196. Double-blind RCT, N≈20 trained cyclists, CordyMax Cs-4 3 g/d × 5 wk — NULL primary on VO₂max, TTE, ventilatory threshold.
Zhang HW, et al. (2014). Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev. PMID 25519252. SR/MA 22 RCTs, N=1,746 — reduced proteinuria + creatinine vs control, high RoB.
Park J, et al. (2015). Cordyceps militaris Enhances Cell-Mediated Immunity in Healthy Korean Men. PMID 26284906. RCT N=79, 1.5 g/d × 4 wk — NK cell + T-cell biomarker elevation.
Colson SN, et al. (2005). Cordyceps sinensis- and Rhodiola rosea-based supplementation in male cyclists. J Strength Cond Res. PMID 15903375. Double-blind RCT N≈18 — NULL primary on muscle tissue oxygen saturation. First Endurance Optygen branded.
Wu Y, et al. (2024). Efficacy of traditional Chinese medicine Cordyceps sinensis as an adjunctive treatment in patients with renal dysfunction. PMID 39839641. SR/MA — adjunctive arm reduces 24h proteinuria + creatinine vs ACEI/ARB alone.
Du X, et al. (2023). The effects of Ophiocordyceps sinensis combined with ACEI/ARB on diabetic kidney disease. Heliyon. PMID 36375237. SR/MA DKD — favourable direction, high heterogeneity.
Liu Y, et al. (2024). Adjuvant treatment with Cordyceps sinensis for lung cancer. PMID 38484953. SR/MA — improved KPS + immune indices, tumor response unchanged.
Zhou X, et al. (2017). Efficacy of Cordyceps sinensis as an adjunctive treatment in kidney transplant patients. PMID 28137532. SR/MA 5 RCTs N≈381 — reduced acute rejection + infection rate.
Wang Y, et al. (2019). Efficacy of Cordyceps sinensis as an adjunctive treatment in hemodialysis patients. Ren Fail. PMID 32186018. GRADE-assessed + high I² — direction only.
Lee J, et al. (2024). A randomized controlled clinical trial examining the effects of Cordyceps militaris beverage on the immune response in healthy adults. PMID 38580687. RCT — biomarker direction favourable, URI inconclusive.
Kang HJ, et al. (2021). Safety Assessment of HEA-Enriched Cordyceps cicadae Mycelium: A Randomized Clinical Trial. Nutrients. PMID 32702252. Safety RCT N=60 ≤3 g/d × 12 wk — no clinically meaningful AE.
Hirsch KR, et al. (2017). Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. J Diet Suppl. [cite-unverified] Preflight-anchored Aloha-Medicinals-funded healthy-adult RCT.
ClinicalTrials.gov NCT07310108. Lindenwood University / Kerksick et al. — Cordyceps militaris MS-116-04 for exercise performance, endurance, cardiovascular fitness, GI wellness, mood, and recovery. 2025-registered, active. [cite-unverified] Pipeline trial; not yet reported.
Liu Y, et al. (2024). A systematic review on polysaccharides from fermented Cordyceps sinensis. PMID 39510481. Preparation-dependent compositional variability confirmed.